Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Deferred Taxes: 2011-2018

Historic Deferred Taxes for Niagen Bioscience (NAGE) over the last 6 years, with Dec 2018 value amounting to $2,000.

  • Niagen Bioscience's Deferred Taxes fell 100.00% to -$16,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $2,000, marking a year-over-year decrease of 98.89%. This contributed to the annual value of $2,000 for FY2018, which is 98.89% down from last year.
  • Latest data reveals that Niagen Bioscience reported Deferred Taxes of $2,000 as of FY2018, which was down 98.89% from $180,000 recorded in FY2017.
  • Over the past 5 years, Niagen Bioscience's Deferred Taxes peaked at $503,671 during FY2016, and registered a low of -$69,445 during FY2016.
  • Its 3-year average for Deferred Taxes is $154,056, with a median of $91,000 in 2017.
  • As far as peak fluctuations go, Niagen Bioscience's Deferred Taxes spiked by 825.28% in 2016, and later plummeted by 98.89% in 2018.
  • Yearly analysis of 4 years shows Niagen Bioscience's Deferred Taxes stood at -$51,587 in 2015, then slumped by 34.62% to -$69,445 in 2016, then surged by 825.28% to $503,671 in 2016, then slumped by 64.26% to $180,000 in 2017, then slumped by 98.89% to $2,000 in 2018.